This observation is consistent with two recent studies showing that the PP2A contributed to tumor progression through enhancing target gene occupancy of c-Jun and stimulating oncogenic signaling (ERK, AKT and WNT) in colorectal and pancreatic cancer models (58,59). The gene discussed is JUN; the disease is neoplasm.